News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
249,627 Results
Type
Article (20140)
Company Profile (128)
Press Release (229347)
Multimedia
Podcasts (87)
Webinars (16)
Section
Business (73175)
Career Advice (973)
Deals (12885)
Drug Delivery (56)
Drug Development (29571)
Employer Resources (74)
FDA (4063)
Job Trends (4866)
News (119524)
Policy (8679)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (3)
Academia (578)
Accelerated approval (26)
ADA (20)
Adcomms (17)
Allergies (73)
Alliances (21605)
ALS (111)
Alzheimer's disease (754)
Antibody-drug conjugate (ADC) (335)
Approvals (4155)
Artificial intelligence (308)
ASCO (142)
Autoimmune disease (206)
Automation (21)
Bankruptcy (90)
Best Places to Work (3232)
BIOSECURE Act (20)
Biosimilars (125)
Biotechnology (113)
Bladder cancer (104)
Brain cancer (35)
Breast cancer (332)
Cancer (2900)
Cardiovascular disease (179)
Career advice (816)
Career pathing (31)
CAR-T (243)
CDC (8)
Celiac Disease (1)
Cell therapy (634)
Cervical cancer (20)
Clinical research (26558)
Collaboration (1305)
Company closure (6)
Compensation (423)
Complete response letters (51)
COVID-19 (909)
CRISPR (51)
C-suite (779)
Cystic fibrosis (75)
Data (3781)
Denatured (20)
Depression (73)
Dermatology (37)
Diabetes (202)
Diagnostics (1708)
Digital health (13)
Diversity (4)
Diversity, equity & inclusion (21)
Drug discovery (241)
Drug pricing (55)
Drug shortages (3)
Duchenne muscular dystrophy (153)
Earnings (23906)
Editorial (37)
Employer branding (8)
Employer resources (75)
Events (40151)
Executive appointments (658)
FDA (5539)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (24)
Funding (1044)
Gene editing (136)
Generative AI (35)
Gene therapy (493)
GLP-1 (469)
Government (942)
Grass and pollen (2)
Guidances (123)
Healthcare (3394)
Hematology (90)
HIV (23)
Huntington's disease (48)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (73)
Immunology and inflammation (217)
Immuno-oncology (70)
Indications (77)
Infectious disease (1073)
Inflammatory bowel disease (135)
Inflation Reduction Act (4)
Influenza (64)
Intellectual property (146)
Interviews (147)
IPO (5386)
IRA (14)
Job creations (1663)
Job search strategy (719)
JPM (48)
Kidney cancer (9)
Labor market (82)
Layoffs (275)
Leadership (33)
Legal (2031)
Liver cancer (35)
Longevity (19)
Lung cancer (374)
Lymphoma (238)
Machine learning (31)
Management (25)
Manufacturing (624)
MASH (78)
Medical device (1797)
Medtech (1821)
Mergers & acquisitions (8115)
Metabolic disorders (655)
mRNA (128)
Multiple sclerosis (96)
NASH (8)
Neurodegenerative disease (258)
Neuropsychiatric disorders (57)
Neuroscience (1563)
Neurotech (1)
NextGen: Class of 2026 (1598)
Non-profit (513)
Now hiring (54)
Obesity (342)
Opinion (218)
Ovarian cancer (137)
Pain (95)
Pancreatic cancer (149)
Parkinson's disease (218)
Partnered (18)
Patents (275)
Patient recruitment (331)
Peanut (21)
People (26556)
Pharmaceutical (16)
Pharmacy benefit managers (5)
Phase 1 (9545)
Phase 2 (12283)
Phase 3 (7796)
Pipeline (4187)
Policy (158)
Postmarket research (515)
Preclinical (3854)
Press Release (62)
Prostate cancer (112)
Psychedelics (38)
Radiopharmaceuticals (141)
Rare diseases (627)
Real estate (2846)
Recruiting (41)
Regulatory (7966)
Reports (27)
Research institute (604)
Resumes & cover letters (157)
Rett syndrome (21)
RNA editing (20)
RSV (31)
Schizophrenia (56)
Series A (213)
Series B (143)
Service/supplier (6)
Sickle cell disease (53)
Special edition (20)
Spinal muscular atrophy (65)
Sponsored (17)
Startups (2070)
State (1)
Stomach cancer (9)
Supply chain (51)
Tariffs (40)
The Weekly (66)
Vaccines (436)
Venture capital (121)
Weight loss (202)
Women's health (41)
Worklife (11)
Date
Last 7 days (249)
Last 30 days (1140)
Last 365 days (13535)
2026 (6929)
2025 (13368)
2024 (14555)
2023 (15629)
2022 (20798)
2021 (21192)
2020 (17480)
2019 (12321)
2018 (9658)
2017 (11549)
2016 (10443)
2015 (12297)
2014 (11989)
2013 (11228)
2012 (8142)
2011 (8536)
2010 (7801)
Location
Africa (386)
Alabama (62)
Alaska (3)
Arizona (90)
Arkansas (4)
Asia (30213)
Australia (4536)
California (5747)
Canada (1682)
China (898)
Colorado (120)
Connecticut (211)
Delaware (133)
Europe (41217)
Florida (710)
Georgia (95)
Hawaii (2)
Idaho (14)
Illinois (302)
India (72)
Indiana (278)
Iowa (8)
Japan (403)
Kansas (30)
Kentucky (9)
Louisiana (9)
Maine (4)
Maryland (743)
Massachusetts (4564)
Michigan (134)
Minnesota (273)
Mississippi (1)
Missouri (38)
Montana (12)
Nebraska (8)
Nevada (50)
New Hampshire (11)
New Jersey (1461)
New Mexico (11)
New York (1413)
North Carolina (806)
North Dakota (6)
Northern California (2838)
Ohio (128)
Oklahoma (11)
Oregon (12)
Pennsylvania (1057)
Puerto Rico (14)
Rhode Island (20)
South America (485)
South Carolina (11)
Southern California (2324)
Tennessee (36)
Texas (814)
United States (19355)
Utah (105)
Vermont (1)
Virginia (106)
Washington D.C. (26)
Washington State (671)
West Virginia (1)
Wisconsin (46)
249,627 Results for "panacea biotech ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025
May 15, 2026
·
3 min read
Opinion
Direct-to-Consumer Drugs Are Not a Panacea for High Costs
TrumpRX and DTC sales may expand prescription drug access, but they will not solve the affordability crisis by themselves.
March 6, 2026
·
4 min read
·
Michael Grosberg
China
New biotech group rises to fuel American rockets in China ‘space race’
Members of the American Biotech Innovation Alliance (ABIA) want to build a national biotech strategy—just like China did years ago.
June 10, 2026
·
3 min read
·
Annalee Armstrong
China
No longer a bargain pool, Chinese biotechs command higher premiums
Deal dynamics between Chinese biotechs and global pharma companies are changing fast, with the biotechs seeking higher upfront payments and the Big Pharmas seeking more expansive platform deals.
June 3, 2026
·
5 min read
·
Leslie Zhen Liang
Press Releases
Panacea Capital Leads Formation of Seismic Pharma to Advance Novel, Clinical-Stage Heart Failure Portfolio
March 30, 2026
·
3 min read
Insights
Portugal, Spain and the new biotech frontier
In this episode of Denatured, you’ll be hearing from Hannah Franklin, associate at Biovance Capital and Pablo Gabriel Cironi Lopez, director of life science investment at Caixa Capital Risc as they discuss the rise of Southern Europe’s biotech ecosystem.
June 11, 2026
·
1 min read
·
Jennifer C. Smith-Parker
IPO
Biotech’s IPO tide is finally turning, thanks in part to the recent M&A surge
After years of suffering from a bear market and more than 14 months of geopolitical turmoil shaking the macroenvironment, biotech appears to be moving on.
May 12, 2026
·
5 min read
·
Gabrielle Masson
Insights
France’s biotech ecosystem: science, capital and scale
In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you’ll be hearing from Ksenija Pavletic, partner and chief commercial officer at Jeito Capital and Thierry Laugel, managing partner at Kurma Partners. We dive into France’s biotech ecosystem and what still needs to happen for more early innovation to translate into investable, scalable biotech.
May 28, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Company closure
6 biotechs that called it quits in Q1
Six biotechs based in California, Massachusetts, Washington and Denmark had to halt drug development efforts this year. One of their CEOs is now in an interim chief executive role at another biotech.
April 30, 2026
·
6 min read
·
Angela Gabriel
IPO
Sky-high Parabilis, Kailera IPOs spur optimism—but only for derisked biotechs
Biotechs are benefitting from the AI tech frenzy and inflation, but validated pipelines and careful planning are still key to the recent record-setting IPOs, experts say.
June 11, 2026
·
5 min read
·
Annalee Armstrong
1 of 24,963
Next